Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick"s: the Testicular Cryopreservation Consortium (TCC). For a description of this project, "Translating the Science of Testicular Tissue Cryopreservation," see the consortium grant made to the lead institution: the Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium which is being funded by St. Baldrick"s: the Testicular Cryopreservation Consortium (TCC). For a description of this project, "Translating the Science of Testicular Tissue Cryopreservation," see the consortium grant made to the lead institution: the Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This grant funds a clinical research assistant to support the Late Effects/Survivorship program.

This grant will be used to hire a pediatric oncology nurse practitioner to help organize and coordinate a pediatric oncology survivorship clinic.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant funds a staff person to manage the Long-Term Survivor Clinic, providing comprehensive care including the enrollment of patients in long-term research studies.

This grant funds the development of a comprehensive long-term follow-up program to monitor and treat secondary cancers and the many other health issues that young cancer patients face as they enter into adulthood.

Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials, significantly increasing clinical trial participation. This grant provides personnel vital to this unique effort.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant is to develop a limited, multi-institutional research consortium aimed at effectively conducting therapeutic trials in cancer survivors. Funds administered by the University of Minnesota - Twin Cities.

With every new pediatric cancer diagnoses, a family is given the most unexpected and stressful news of their lives. This kind of stress makes people more susceptible to post-traumatic stress and depression, and also diminishes the immune system, allowing the body to become sick more often. This project examines the level of chronic stress felt by the parents of children and the factors involved. It is vital that we work to improve the outcomes for both patients and their families.

Cancer affects every part of patients and their families' lives. Self-image, thinking clearly, anxiety, depression, social isolation and fear of recurrence are all problems that teens and young adults with cancer face, while resuming normal development and being monitored for many problems caused by cancer and its treatment. This research is to create developmentally sensitive information and make it available through touch-screen technology, connecting teens and young adults with their health care team and community resources in real-time. This helps identify, communicate and maximize the benefits of clinical care while helping them reintegrate into school and work.

Based on progress to date, Dr. Fish was awarded a new grant in 2011 to fund an additional two years of this Scholar award. Since over 75% of children with cancer can now be cured, the population of 250,000 survivors of childhood cancer in the USA is rapidly growing. Over 60% of survivors have a chronic medical problem, and 27% a severe or life-threatening problem as a result of their treatment. Research into problems faced by survivors is critical to improving their care. Dr. Fish investigates whether care in a specialized center will improve: 1) patient awareness of treatments they received and risks they face because of those treatments; and 2) the ability of survivors to follow medical recommendations and referrals.

Many children survive cancer, but treatments that save lives can also damage the heart, placing survivors at risk for serious health problems later in life. Dr. Toro-Salazar and colleagues will utilize a pilot study to test EX@HOME. The 16-week, home-based exercise program is designed to help childhood cancer survivors safely improve fitness and protect heart health soon after completing therapy. EX@HOME uses a simple mobile app, a wearable fitness watch, and regular coaching support to make healthy physical activity accessible and sustainable for families. Results will provide critical early evidence to guide larger trials and support the development of scalable survivorship care programs, helping ensure that children not only survive cancer, but also go on to live long, healthy lives.

Teens with leukemia go through tough treatments that make them feel tired and weak. This leads them to spend a lot of time sitting and lying down, which can worsen side effects and increase risk for chronic diseases like heart disease and diabetes. ReSeT1, is a program designed by Dr. Ivory to help teens receiving leukemia treatment reduce sitting time by taking short activity breaks using a Fitbit, health coaching, and an app-based chat group. Using an enhanced version called ReSeT2, which includes home activity equipment, additional coaching, peer support groups, and goal-based rewards, Dr. Ivory and colleagues will test 20 new teens comparing them to 20 who do not receive the program to see if it works. Small behavior changes will help cancer patients become more active during and after treatment to improve lifelong health.